** Bernstein initiates Eurofins Scientific EUFI.PA with a
"market-perform" rating, citing the ongoing saga with Muddy
Waters after the short-seller questioned the French lab testing
firm's financial statements
** "Lack of transparency damages what was meant to be a good
year," Bernstein says, but is more upbeat about future prospects
** "In our view, the current weak valuation stems solely
from the MW allegations and does not reflect future operations,"
it says
** Eurofins has nonetheless underperformed the commercial &
professional services and healthcare equipment sectors, with
investors worried about its margins in 2024, it adds
** "We see further margin upside in the US that investors
seem to be overlooking right now" - Bernstein
** It sets a PT of 52.8 euros; Eurofins currently trades at
around 48.9 euros
** Out of 16 analysts that cover Eurofins, six rate the
stock "strong buy" or "buy", five "hold", and five "strong
sell" or "sell"
(Reporting by Olivier Sorgho)
((Olivier.Sorgho@thomsonreuters.com))